The brewer told hospitality customers to push half pints, low and no alcohol drinks and small plates. Diageo and Carlsberg see less of an impact.
Recap by typeshit. Full story at The Guardian.
General exercise advice aimed at GLP-1 users, shared on Facebook with no study or expert named in the material available.
Gilead takes global rights to the Shanghai biotech's program, led by HCXT-2001, an oral peptide that could compete with injected IBD drugs.
A Facebook promo for a podcast episode on the ripple effects of GLP-1 consumers across businesses. Few details beyond the pitch.
10:49
xitsnemox posts a short check-in from week 14 on oral Wegovy, two weeks after stepping up to the 25mg tablet. A personal account, not medical advice.
The same variant also raised odds of nausea and vomiting, and tirzepatide users carrying two variants had 14.8 times the odds of vomiting, researchers report.
Reuters reports the Indian drugmaker widened its generic semaglutide lineup, based on product photos and marketing material it reviewed.
Loading…